Knutsford, United Kingdom

John Preston


Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 189(Granted Patents)


Location History:

  • Macclesfield, EN (1977 - 1978)
  • Knutsford, GB (1983 - 2004)
  • Macclesfield, GB (1978 - 2005)
  • Cheshire, GB (2007)

Company Filing History:


Years Active: 1977-2007

Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovations in Antithrombotic and Anticoagulant Agents by John Preston

Introduction

John Preston, an accomplished inventor residing in Knutsford, GB, has significantly contributed to the field of medicinal chemistry with a remarkable portfolio of 23 patents. His innovative work focuses on the development of novel compounds that exhibit antithrombotic and anticoagulant properties, providing promising solutions for medical treatments.

Latest Patents

Among his latest patents, Preston has described aminoheterocyclic derivatives as effective antithrombotic or anticoagulant agents. These compounds, characterized by specific structural formulas and variations in substituents, highlight the potential to selectively inhibit Factor Xa, a critical component in the blood coagulation pathway. His invention outlines various processes for the preparation of these derivatives and details pharmaceutical compositions that contain them, thereby marking an advancement in therapeutic approaches for cardiovascular diseases.

Another patent focuses on heterocyclic derivatives that also possess antithrombotic and anticoagulant properties. These derivatives are presented with clear structural formulas and are claimed to be useful in medical treatments aimed at preventing thrombotic events. The innovative processes for creating these compounds and their applications in producing effective medicaments further solidify Preston’s influence in the pharmaceutical industry.

Career Highlights

John Preston’s professional journey includes valuable tenure at prominent organizations such as Imperial Chemical Industries Limited and Zeneca Limited. His experience in these companies has laid the foundation for his groundbreaking work in drug development and innovative chemical solutions.

Collaborations

Throughout his career, John Preston has collaborated with distinguished professionals, including Andrew Stocker and Steven P. Brown. These partnerships have fostered the exchange of ideas and expertise, contributing to the successful advancement of numerous projects in medicinal innovation.

Conclusion

John Preston’s inventive spirit and expertise have led to significant advancements in the field of antithrombotic and anticoagulant agents. As he continues to develop innovative compounds and processes, his contributions will undoubtedly influence future medical treatments and improve patient outcomes in the fight against thrombotic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…